Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Silvia Weineck"'
Autor:
Ingo G.H. Schmidt-Wolf, Angela Märten, Peter Albers, Ludmila Krizek, Peter Hanfland, Cora Faber, Dimitri Flieger, Alexander von Ruecker, Carsten Ziske, Silvia Weineck, Björn Schöttker, Sabine Renoth, Tilman Sauerbruch, Markus Compes, Steffen Engelhart, Stefan Müller
Publikováno v:
Cancer Immunology, Immunotherapy. 51:637-644
In this study we have presented in vitro data and results of a preliminary clinical trial using dendritic cells (DC) in patients with progressive metastatic renal cell carcinoma. DC precursor cells were obtained from peripheral blood mononuclear cell
Autor:
Peter Buttgereit, Angela Märten, Frank Schakowski, A Allera, Sabine Renoth, Ingo G.H. Schmidt-Wolf, S König, Tilman Sauerbruch, Carsten Ziske, A. von Rücker, Burghardt Wittig, Silvia Weineck, Björn Schöttker, Roland Schroers
Publikováno v:
Cancer Gene Therapy. 8:211-219
Dendritic cells (DCs) are the major antigen-presenting cells. They are able to present tumor antigens to immunologic effector cells. MHC class II molecules on DC surfaces play an important role in priming effector cells against tumor cells and their
Autor:
Andreas E. Albers, Thomas Bieber, Tomislav Dorbic, Stefan Müller, Susanne Kruopis, Andreas Neubauer, Sigrun Niemitz, Tilman Sauerbruch, Beate Trojaneck, Angela Märten, Dieter Huhn, Burghardt Wittig, Jürgen Löffel, Ingo G.H. Schmidt-Wolf, Dimitri Flieger, Silvia Weineck, Heshon Min, Peter Albers
Publikováno v:
Human Gene Therapy. 12:267-278
Therapeutic vaccination of tumor patients with cytokine gene-transfected tumor cells leads to tumor regression in animal models but has so far not resulted in significant clinical benefit. We and others demonstrated that tumor cells transfected to me
Autor:
Tilman Sauerbruch, Sabine Renoth, Carsten Ziske, Christian Scheffold, Angela Märten, Frank Schakowski, Silvia Weineck, Björn Schöttker, Dietrich Klingmüller, Ingo G.H. Schmidt-Wolf, Alexander von Rücker, Peter Buttgereit
Publikováno v:
International Journal of Colorectal Disease. 15:197-205
Both we and others have observed a relative resistance of solid tumor cells to immunological effector cells in vitro, which may be one reason for the clinical phenomenon of resistance of patients with pancreatic carcinoma or other solid tumors to imm
Autor:
Angela Märten, Peter Buttgereit, Ingo G.H. Schmidt-Wolf, Petja Lefterova, Christian Scheffold, Dieter Huhn, Silvia Weineck
Publikováno v:
Journal of Immunotherapy. 23:304-310
Recently, highly efficient natural killer-like T immunologic effector cells called cytokine-induced killer (CIK) cells have been described. Most interestingly, CIK cells have been shown to eradicate established human lymphoma cells in a severe combin
Autor:
von Rücker A, Ingo G.H. Schmidt-Wolf, Tilman Sauerbruch, Peter Buttgereit, Silvia Weineck, Björn Schöttker, Sabine Renoth, Carsten Ziske, Angela Märten, Frank Schakowski
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 24(6)
Dendritic cells (DCs) are major antigen-presenting cells. They are capable of capturing and processing tumor antigens, expressing lymphocyte costimulatory molecules, and secreting cytokines to initiate immune responses. Here, the authors tested the e
Autor:
Angela Märten, Ingo G.H. Schmidt-Wolf, Dieter Huhn, Peter Buttgereit, Karsten Brand, Silvia Weineck, Thomas Heinicke, Wolfgang H. Caselmann, Gabriele Röpke
Publikováno v:
Cancer gene therapy. 7(8)
Tumor cells, such as lymphoma cells, are possible targets for gene therapy. In general, gene therapeutic approaches require efficient gene transfer to host cells and sufficient transgene expression. However, lymphoma cells previously have been demons
Autor:
Peter Buttgereit, Björn Schöttker, Tilman Sauerbruch, Angela Märten, Silvia Weineck, Dieter Huhn, Ingo G.H. Schmidt-Wolf, Carsten Ziske
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 23(4)
Previously, a relative resistance of solid tumor cells to immunologic effector cells was shown in vitro. This resistance could be one reason for the clinical phenomenon of resistance of patients with colon carcinoma or other solid tumors to immunolog